Antitrust laws in the generic drug market prevent big pharma from blocking cheaper alternatives through pay-for-delay deals, patent abuse, and product hopping. These tactics cost patients billions-here’s how they work and who’s fighting back.
Antitrust laws in the generic drug market prevent big pharma from blocking cheaper alternatives through pay-for-delay deals, patent abuse, and product hopping. These tactics cost patients billions-here’s how they work and who’s fighting back.